File Analysis of Falling Patients: Are Drugs Frequently Involved (ADOPAC)
The damage caused by patient falls is a major public health problem, due to the large and growing number of people concerned, the potentially serious consequences but also the financial cost generated by their care.
These consequences can be physical as well as psychological. Fractures and pain are the first consequences that come to mind, but many others should be mentioned: post-fall syndrome, loss of autonomy or even entering an institution, fear of falling, loss of confidence in itself.
調査の概要
詳細な説明
During 2018, 285 reports of falls were counted within the Paris Saint-Joseph Hospital Group (GhPSJ). Reducing these falls is one of the institutional goals. A dedicated working group has been created to put in place preventive and corrective measures.
These falls can be caused by many factors to the patient:
Intrinsic:
- History of a fall,
- pathologies (Parkinson's or Alzheimer's disease),
- hearing and visual disturbances,
- urinary incontinence.
extrinsic:
- Unsuitable shoes
- unsuitable habitat,
- slippery floors (eg bathroom).
Among the intrinsic factors, polypharmacy is also found. It has been established that certain drug classes are at risk of falling, in particular psychotropic drugs (benzodiazepines, hypnotics, anxiolytics, antidepressants, neuroleptics) which promote sedation and dizziness, hypoglycemic drugs which cause hypoglycaemia in diabetic patients on -treated or antihypertensive drugs causing hypotension.
It is now clearly established that drug adherence to treatment is poor in cities, giving rise to omissions but also sometimes to overconsumption of certain drugs, including psychotropic drugs.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Ile De France
-
Paris、Ile De France、フランス、75014
- Groupe Hospitalier Paris Saint-Joseph
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Major patient
- French-speaking patient
- Patient hospitalized within the Paris Saint-Joseph Hospital Group
- Patient who fell during hospitalization and for whom a fall report has been completed
Exclusion Criteria:
- Patients in the process of therapeutic limitation
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient objecting to participation in the study
- Patient under legal protection
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
---|---|
Patients
From Monday to Friday, the study will be offered to patients selected consecutively and who have fallen within the previous 24 hours (between 7.55 a.m. the day before and 7.55 a.m. the next day). After delivery of the written information note to the patient, the investigating physician answers the patient's questions and accepts his non-objection. The patient should be given sufficient time to think things through to make the decision to participate in the study. Its non-opposition will be traced in the computerized medical file created on the day of its inclusion in the protocol. Each patient participating in the study retains the possibility of participating simultaneously in another research. No exclusion period is provided for in the protocol. |
Once the patient is included, a drug assessment is carried out as part of the treatment and then an compliance questionnaire is submitted to him.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
To assess the prevalence of falls associated with one or more risk factors for drug iatrogenism within the Paris Saint-Joseph Hospital Group.
時間枠:1 week
|
Percentage of falls involving one or more drugs at risk of falling
|
1 week
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
List the drug treatments at risk taken by patients who fall
時間枠:1 week
|
To list the drug treatments taken by the patients who fall: carrying out the patient's drug assessment
|
1 week
|
Evaluate the relevance of drug prescriptions in patients who fall
時間枠:1 week
|
Average number of inappropriate medication prescriptions per patient
|
1 week
|
Evaluate the overall compliance of falling patients
時間枠:1 week
|
Average compliance score in patients who fall
|
1 week
|
協力者と研究者
捜査官
- 主任研究者:Elodie MENAGE、Groupe Hospitalier Paris Saint Joseph
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
No interventionの臨床試験
-
University of California, San FranciscoSan Francisco Veterans Affairs Medical Center; Tobacco Related Disease Research Program完了
-
University of MichiganNational Institute on Drug Abuse (NIDA)募集
-
University of PittsburghCenters for Disease Control and Preventionまだ募集していません暴力, ドメスティック | 思春期の暴力 | 暴力、性的 | 暴力、身体的 | 暴力, 偶然ではない | 社会的結束 | 暴力、構造 | コミュニティ内暴力アメリカ
-
University of Southern CaliforniaNational Institutes of Health (NIH)積極的、募集していない
-
Massachusetts General HospitalNational Institutes of Health (NIH); Samaritans of Bostonまだ募集していません自殺念慮 | 自殺未遂 | 自殺